Neuroprotective effects of glycine for therapy of acute ischaemic stroke

Cerebrovascular Diseases

Volumn 10, Issue 1, 2000, Pages 49-60

  Gusev, E I ^a   Skvortsova, V I ^a,d   Dambinova, S A ^c   Raevskiy, K S ^b   Alekseev, A A ^a   Bashkatova, V G ^b   Kovalenko, A V ^a   Kudrin, V S ^b   Yakovleva, E V ^a  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^c RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^d Russian Medical University   (Russian Federation)

Author keywords

Acute cerebral ischaemia; Clinical trials; Glycine; Neuroprotection

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; AUTOANTIBODY; GLUTAMIC ACID; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL DISEASE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROPROTECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; STROKE;

ACUTE DISEASE; AGED; AMINO ACIDS; AUTOANTIBODIES; CEREBROVASCULAR ACCIDENT; DOUBLE-BLIND METHOD; FEMALE; GLYCINE; HEMODYNAMIC PROCESSES; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; RECEPTORS, N-METHYL-D-ASPARTATE; TREATMENT OUTCOME;

EID: 0033982957     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016025     Document Type: Article

References (51)

1. Ginsberg MD, Globus MY-T, Busto R, Dietrich WD: The potential of combination pharmacotherapy in cerebral ischemia; in Krieglstein J, Oberpichler H (eds): Pharmacology of Cerebral Ischemia. Stuttgart, Wissenschaftliche Verlagsgesellschaft, 1990, pp 499-510.
2. Fisher MA: Clinical pharmacology of cerebral ischemia: Old controversies and new approaches. J Cerebrovasc Dis 1991;1:112-119.
3. Scheinberg P: The biologic basis for the treatment of acute stroke. Neurology 1991;41: 1867-1873.
4. Giroux C, Scatton B: Ischemic stroke: Treatment on the horizon. Eur Neurol 1996;36:61-64.
5. O'Neill M, Allain H, Bentue-Ferrer D, Bellissant E, de Certaines J, Leonard BE: Pharmacological strategies in the treatment of cerebral ischemia. Eur Neurol 1995;35:28-36.
6. Silver B, Weber J, Fisher M: Medical therapy for ischemic stroke. Clin Neuropharmacol 1996;19:101-128.
7. Johnson JW, Ascher P: Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987;325:529-531.
8. Kleckner NW, Dingledine R: Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science 1988;24: 835.
9. Henderson G, Johnson J, Ascher P: Competitive antagonists and partial agonists at the glycine modulatory site of the N-methyl-d-aspartate receptor. J Physiol 1990;430:189-212.
10. Patel J, Zinkand WC, Thompson C, Keith R, Salama A: Role of glycine in the N-methyl-d-aspartate-mediated neuronal cytotoxicity. J Neurochem 1990;54:849-854.
11. Thomson AM: Glycine is a coagonist at the NMDA receptor/channel complex. Prog Neurobiol 1990;35:53-74.
12. Kemp JA, Leeson PD: The glycine site of the NMDA receptor - Five years on. Trends Pharmacol Sci 1993;14:20-25.
13. Beaughard M, Michelin M, Massingham R: Effects of the putative glycine antagonist HA-966 on the neurological and histological changes induced by transient global ischemia in rats and gerbils; in Krieglstein J, Oberpichler H (eds): Pharmacology of Cerebral Ischemia. Stuttgart, Wissenschaftliche Verlagsgesellschaft, 1990, pp 275-280.
14. Priestley T, Horne AL, McKernan RM, Kemp JA: The effect of NMDA receptor glycine site antagonists on hypoxia-induced neurodegeneration of rat cortical cell cultures. Brain Res 1990;531:183-188.
15. Buchan A, Hui L, Pulsinelli WA: The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J Neurosci 1991;11:1049.
16. Croucher MJ, Bradford HF: The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds. Brain Res 1991;543:91-96.
17. Carter AJ: Glycine antagonists: Regulation of the NMDA receptor-channel complex by the strychnine-insensitive glycine site. Drugs Future 1992;17:595-613.
18. von Lubitz DKJE, Lin RC-S, McKenzie RJ, Devlin TM, McCabe RT, Skolnick P: A novel treatment of global cerebral ischaemia with a glycine partial agonist. Eur J Pharmacol 1992; 219:153-158.
19. Loscher W, Wlaz P, Rundfeldt C, Baran H, Honack D: Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Br J Pharmacol 1994;112: 97-106.
20. Chizhmakov IV, Kishin NI, Krishtal OA, Tsyndrenko AY: Glycine action on N-methyl-D-aspartate receptors in rat hippocampal neurons. Neurosci Lett 1989;99:131-136.
21. Jones MG, Szatkowski MS: The role of glycine in anoxia/aglycaemia-induced potentiation of N-methyl-D-aspartate receptor-mediated post-synaptic potentials in the rat hippocampus. Neurosci Lett 1995;201:227-230.
22. Obrenovitch TP, Urenjak J, Zilkha E: Intrace-rebral microdialysis combined with recording of extracellular field potential: A novel method for investigation of depolarizing drugs in vivo. Br J Pharmacol 1994;113:1295-1302.
23. Obrenovitch TP, Hardy AM, Urenjak J: High extracellular glycine does not potentiate N-methyl-D-aspartate-evoked depolarization in vivo. Brain Res 1997;746:190-194.
24. James TA, Starr MS: Is glycine an inhibitory synaptic transmitter in the substantia nigra? Eur J Pharmacol 1979;57:115-125.
25. Fagg GE, Foster AC: Amino acid neutrotransmitters and their pathways in the mammalian central nervous system. Neuroscience 1983;9: 701-719.
26. Mayor F, Valdivieso F, Ugar M: Some aspects of glycine neurochemistry. J Amino Acid Neurotransmitters Adv Biochem Psychopharmacol 1991;29:551-560.
27. Lapin IP: Antagonism of glycine to seizures induced by L-kynurenic, quinolinic acid and strychnine in mice. Eur J Pharmacol 1981;71: 495-498.
28. Toth E, Lajtha A, Sarhan S, Seiler N: Anticonvulsant effects of some inhibitory amino acids. Neurochem Res 1983;8:291-302.
29. Peterson SL, Boehnke LE: Anticonvulsant effects of MK-801 and glycine on hippocampal afterdischarge. Exp Neurol 1989;104:113-117.
30. Scolnick P, Marvizon J, Jackson B, Monn J, Rice K, Lewin A: Blockade of N-methyl-D-aspartate-induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci 1989;45: 1647-1655.
31. Stark L, Peterson SL, Albertson TE: Pharmaco logical and toxicological evaluation of potential antiepileptic drugs in the kindling model of epilepsy; in Wada JA (ed): Kindling 4. New York, Raven Press, 1990, pp 267-281.
32. Tricklebank MD, Saywell K: Behavioral properties of antagonists acting at the glycine modulatory site on the NMDA receptor/ion channel complex. Soc Neurosci Abstr 1990;16:462.
33. Peterson SL, Schwade ND: The anticonvulsant activity of D-cycloserine is specific for tonic convulsions. Epilepsy Res 1993;15:141-148.
34. Peterson SL: Anticonvulsant drug potentiation by glycine in maximal electroshock seizures is mimicked by D-serine and antagonized by 7-chlorokynurenic acid. Eur J Pharmacol 1991; 199:341-348.
35. Meister A: Biochemistry of the Amino Acids. New York, Grune and Stratton, 1957.
36. Williams R: Biogenesis of products of conjugation and detoxication; in Dernfeld R (ed): Biogenesis of Natural Compounds. New York, Grune and Stratton, 1963, pp 368-404.
37. Lavretskaya EF: Pharmacological regulation of mental processes (in Russian). Moscow, Science, 1985.
38. Raevskiy KS, Romanova GA, Kudrin VS, Malikova LA: Neurotransmitter amino acids balance and disturbance of the brain integrative activity produced by the frontal lobe focal ischemia: Effects of piracetam and glycine. Bull Exp Biol Med 1997;123:370-373.
39. Badikov VI, Gitel EP, Ivanova NYa, Ivolgina GI, Fedyanina NG, Zaitsev DA, Myasoedov NF, Sudakov KV: Amino acids and delta-sleep inducing peptide (DSIP) distribution in organism after administration in eye conjunctiva of the rabbit. Bull Exp Biol Med 1990;110:236-237.
40. Davalos A, Naveiro J, Noya M: Neuroexcitatory amino acids in relationship to infarct size and neurological deficit in stroke. Stroke 1996; 27:1060-1065.
41. Romanova GA, Kudrin VS, Malikova LA: Correction by glycine and piracetam of the alterations in neurotransmitter amino acids and high integration functions of brain after focal cortex ischemia. Pharmacol Res 1995; 31(suppl):128.
42. Komissarova IA, Gudkova JuV, Soldatenkova TD, Kondrashova TT, Burbenskaja NM: Medicinal preparation of antistress, stress-protective and nootropic effect. Patent Bull Russian Fed, 1992, N 2025124.
43. Scandinavian Stroke Study Group: Multicenter trial of hemodilution in ischemic stroke: Background and study protocol. Stroke 1985; 16:885-890.
44. Orgogozo JM, Dartigues JF: Clinical trials in acute brain infarction: The question of assessment criteria; in Battistini N, Courbier R, Fieschi C, Fiorani P, Plum F (eds): Acute Brain Ischemia: Medical and Surgical Therapy. New York, Raven Press, 1986, pp 282-289.
45. Mahoney FI, Barthel DW: Functional evaluation: The Barthel Index. Md State Med J 1965; 14:61-65.
46. Granger CV, Hamilton BR, Gresham GE, Kramer AA: The stroke rehabilitation outcome study. II. Relative merits of the total Barthel Index score and a four-item subscore in predicting patient outcomes. Arch Phys Med Rehabil 1989;70:100-103.
47. Dambinova SA: Immunosorbent for diagnosis of epilepsy and group risk. Eur Patent Bull, 1993, 93/69 WO 93/00586.
48. Ohkawa H, Ohisi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-355.
49. Castillo J, Davalos A, Noya M: Progression of ischemic stroke and excitotoxic amino acids. Lancet 1997;349:79-83.
50. Gusev EI, Skvortsova VI, Raevskiy KS, Kudrin VS, Sokolov MA, Alekseev AA: Concentrations of neurotransmitter amino acids in cerebrospinal fluid in patients with acute hemispheric ischemic stroke. Meeting of the European Federation of Neurological Societies. Eur J Neurol 1997;4:152/78.
51. Gusev EI, Skvortsova VI, Izykenova GA, Alekseev AA, Dambinova SA: Study of levels of autoantibodies to glutamate receptors in serum in patients with acute ischemic stroke (in Russian). Korsakoff J Neurol Psychiatry 1996;5: 68-72.